A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
University of Iowa
University of Iowa
University of Iowa
Case Comprehensive Cancer Center
Medical College of Wisconsin
University of Iowa
INSYS Therapeutics Inc
Novartis
National Institutes of Health Clinical Center (CC)